1. P640 Serologic response and safety after third dose of the COVID-19 BNT162b2 vaccine in patients with Inflammatory Bowel Diseases. (30th January 2023) Authors: Edelman-Klapper, H; Rabinowitz, K M; Zittan, E; Bar-Gil Shitrit, A; Goren, I; Avni-Biron, I; Ollech, J E; Lichtenstein, L; Banai-Eran, H; Yanai, H; Snir, Y; Pauker, M H; Friedenberg, A; Levy-Barda, A; Segal, A; Broitman, Y; Maoz, E; Ovadia, B; Aharoni Golan, M; Shachar, E Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i772 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. UniPR129 is a competitive small molecule Eph‐ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations. (28th August 2014) Authors: Hassan‐Mohamed, I; Giorgio, C; Incerti, M; Russo, S; Pala, D; Pasquale, E B; Zanotti, I; Vicini, P; Barocelli, E; Rivara, S; Mor, M; Lodola, A; Tognolini, M Journal: British journal of pharmacology Issue: Volume 171:Number 23(2014:Dec.) Page Start: 5195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗